PathAI is a company in the field of artificial intelligence, developing the world’s first AI-powered technology specifically for pathology laboratories. With a mission to improve patient outcomes, PathAI combines AI and meaningful collaboration with biopharma, laboratories, and clinicians to provide patients with access to accurate diagnoses and effective treatments.
Their innovative product, AISight, is a cloud-native intelligent enterprise workflow solution used by leading laboratories and research centers to power their digital pathology workflows and AI applications. With over 450 board-certified pathologists in their proprietary network contributing more than 15 million annotations, PathAI leverages this data to train and validate their AI-based algorithms. This enables them to deliver transformative tools for pathologists that can accelerate drug development, improve diagnostic accuracy, and expedite the delivery of life-saving therapies to patients.